Appalachian and Mid‑Atlantic Addiction Treatment Network
Appalachian Node
This network runs clinical trials and care projects to find better treatments and supports for people with substance use disorders in Appalachia and nearby cities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11261207 on NIH RePORTER |
What this research studies
If you live in central Appalachia or a nearby city, this program tests new treatments and support programs for people who use drugs. Teams from the University of Pittsburgh, West Virginia University, Penn State, and the University of Maryland partner with a shared electronic health record network to reach both rural and urban communities like Baltimore, Philadelphia, Detroit, and Chicago. The Node conducts community‑informed clinical trials, collects health record and outcome data, and compares which interventions work best in different places. The group has led many prior trials and offers opportunities to join treatment studies at participating medical centers.
Who could benefit from this research
Good fit: Ideal candidates are adults with opioid or other substance use disorders who can attend visits at participating hospitals or clinics in Appalachia or the mid‑Atlantic/urban partner cities.
Not a fit: People without substance use disorders, those unable to travel to participating sites, or those who do not meet trial eligibility criteria are unlikely to receive direct benefit from participation.
Why it matters
Potential benefit: If successful, this work could lead to more effective treatments and support services that reduce overdoses and help people stay in recovery.
How similar studies have performed: The Node has led and joined multiple NIDA CTN trials with strong recruitment and a substantial publication record, so similar approaches have produced useful results previously.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Liebschutz, Jane M. — University of Pittsburgh at Pittsburgh
- Study coordinator: Liebschutz, Jane M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.